Moving Forward from "Fine Particle Fraction: The Good and the Bad"
J Aerosol Med Pulm Drug Deliv
.
2022 Aug;35(4):225-226.
doi: 10.1089/jamp.2022.0017.
Epub 2022 May 4.
Authors
Jolyon P Mitchell
1
,
William Doub
2
,
J David Christopher
3
,
Christopher J Gruenloh
4
,
Rajni B Patel
5
,
Mark Copley
6
,
Steven Tignor
7
,
Stephen W Stein
8
,
Svetlana Lyapustina
9
,
Stephen P Newman
10
Affiliations
1
Jolyon Mitchell Inhaler Consulting Services, Inc., London, Canada.
2
OINDP In Vitro Analysis, Kirkwood, Missouri, USA.
3
Merck Research Laboratories, Merck & Co., Inc., West Point, Pennsylvania, USA.
4
PPD, Part of Thermo Fisher Scientific, Middleton, Wisconsin, USA.
5
Intellectual Designs LLC, Brookfield, Connecticut, USA.
6
Copley Scientific Ltd., Nottingham, United Kingdom.
7
Merck & Co., Inc., Rahway, New Jersey, USA.
8
Kindeva Drug Delivery, Woodbury, Minnesota, USA.
9
Faegre Drinker Biddle & Reath LLP, Washington, District of Columbia, USA.
10
Private Consultant, Hunstanton, United Kingdom.
PMID:
35508023
DOI:
10.1089/jamp.2022.0017
No abstract available
Publication types
Letter
Comment
MeSH terms
Administration, Inhalation*
Particle Size